AggreArch: A Programmable Nano-to-Micro Assembly Platform for Redox-Active Metal Microarchitectures in Infected Wound Repair
ACS Applied Materials & Interfaces · 2026
DOI: 10.1021/acsami.6c13004 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2026. Verfasst von Xuanshuo Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Zheshan West Road, Wuhu, Anhui241001, Ch…. Hauptthemen laut MEDLINE: Wound Healing, Anti-Bacterial Agents, Metal Nanoparticles, Wound Infection. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Gannan Medical University.
Abstract (Originalsprache)
Chronic infected wounds, particularly under diabetic conditions, require antimicrobial biomaterials that combine potent bacterial suppression with host-tissue compatibility. Here, we report AggreArch, a tunable aqueous nano-to-micro assembly platform for constructing hierarchical metal-based microarchitectures with programmable composition, morphology, and biological activity. Using this strategy, we generated Ag-, Cu-, and Mn-based AggreArch variants to demonstrate the compositional extensibility of the platform. Among these variants, the dendritic silver architecture AAAg4 was identified as a representative lead candidate, achieving 99.7% inhibition against multidrug-resistant Escherichia coli (E. coli) at 30 μg mL−1 and 99.8% inhibition against methicillin-resistant Staphylococcus aureus (S. aureus) at 100 μg mL−1, while maintaining >85% cell viability and favorable short-term biosafety. Comparative release studies showed that AAAg4 released only 1–2% of total silver in PBS over 7 days vs ∼7% for conventional AgNPs, confirming architecture-regulated silver availability. Integrated transcriptomic and biochemical analyses indicated that AAAg4 induced a coordinated redox-metabolic stress program involving oxidative imbalance, Fe-S-dependent functions, and respiratory electron-transfer-related processes, while imposing a lower oxidative burden on host cells than freely available Ag+. In diabetic infected wound models, AAAg4 accelerated wound closure (approximately 92% by day 12), markedly reduced bacterial burden, and enhanced collagen deposition to 83.1% vs 36.1% in controls. Similar repair-promoting trends were observed in rabbit ear wounds. Collectively, these findings establish AAAg4 as a representative lead architecture within the AggreArch platform and demonstrate that hierarchical microarchitecture engineering can expand the antibacterial-biosafety window of metal-based wound-facing antimicrobial materials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital of Wannan Medical University (Yijishan Hospital of Wannan Medical University), Zheshan West Road, Wuhu, Anhui241001, China.
- Guanchao Medical Research Institute of Xiamen, Xiamen, China.
- Urology The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China.
ORCID-Profile: Xuanshuo Zhang
Förderung
- Gannan Medical University
Zitieren
APA
Zhang, X., Zhao, J., Xu, Z., Wang, W., Qian, X., Chen, X., Gui, Z., Zhang, X., & He, W. (2026). AggreArch: A Programmable Nano-to-Micro Assembly Platform for Redox-Active Metal Microarchitectures in Infected Wound Repair. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c13004
Vancouver
Zhang X, Zhao J, Xu Z, Wang W, Qian X, Chen X, et al. AggreArch: A Programmable Nano-to-Micro Assembly Platform for Redox-Active Metal Microarchitectures in Infected Wound Repair. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c13004
BibTeX
@article{Zhang2026,
author = {Zhang, Xuanshuo and Zhao, Jie and Xu, Zhengyu and Wang, Wei and Qian, Xueyi and Chen, Xiaolin and Gui, Zeping and Zhang, Xiaoyu and He, Weijie},
title = {AggreArch: A Programmable Nano-to-Micro Assembly Platform for Redox-Active Metal Microarchitectures in Infected Wound Repair},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
doi = {10.1021/acsami.6c13004}
}
EUVIMED